Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02453659Completed
Randomised, open-label trial in nicotine dependence, sponsored by Rhode Island Hospital. Primary endpoint: 7-day point prevalence abstinence from smoking at 6 months. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02453659.